These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 3017619)
1. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease. Heyma P; Harrison LC; Robins-Browne R Clin Exp Immunol; 1986 May; 64(2):249-54. PubMed ID: 3017619 [TBL] [Abstract][Full Text] [Related]
2. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. Heyma P; Harrison LC J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581 [TBL] [Abstract][Full Text] [Related]
3. [Antibodies to Yersinia enterocolitica in immunogenic thyroid diseases]. Petru G; Stünzner D; Lind P; Eber O; Möse JR Acta Med Austriaca; 1987; 14(1):11-4. PubMed ID: 3618088 [TBL] [Abstract][Full Text] [Related]
4. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [TBL] [Abstract][Full Text] [Related]
5. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to Yersinia enterocolitica serotype 3 in autoimmune thyroid diseases. Takuno H; Sakata S; Miura K Endocrinol Jpn; 1990 Aug; 37(4):489-500. PubMed ID: 2083529 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes. Wolf MW; Misaki T; Bech K; Tvede M; Silva JE; Ingbar SH Thyroid; 1991; 1(4):315-20. PubMed ID: 1688156 [TBL] [Abstract][Full Text] [Related]
8. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357 [TBL] [Abstract][Full Text] [Related]
9. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364 [TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. Luo G; Seetharamaiah GS; Niesel DW; Zhang H; Peterson JW; Prabhakar BS; Klimpel GR J Immunol; 1994 Mar; 152(5):2555-61. PubMed ID: 7510749 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients. Hill BL; Erlanger BF Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350 [TBL] [Abstract][Full Text] [Related]
12. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors. de Bruin TW; van der Heide D Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495 [TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. Arscott P; Rosen ED; Koenig RJ; Kaplan MM; Ellis T; Thompson N; Baker JR J Clin Endocrinol Metab; 1992 Jul; 75(1):295-300. PubMed ID: 1619022 [TBL] [Abstract][Full Text] [Related]
14. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease. Davies TF; Platzer M Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261 [TBL] [Abstract][Full Text] [Related]
15. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes. Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of the binding of Graves' immunoglobulins by the patients own and other thyroid membranes. Gossage AA; Byfield PG; Copping S; Himsworth RL Clin Endocrinol (Oxf); 1981 Mar; 14(3):301-10. PubMed ID: 6894892 [TBL] [Abstract][Full Text] [Related]
18. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease. Hargreaves CE; Grasso M; Hampe CS; Stenkova A; Atkinson S; Joshua GW; Wren BW; Buckle AM; Dunn-Walters D; Banga JP J Immunol; 2013 Jun; 190(11):5373-81. PubMed ID: 23630351 [TBL] [Abstract][Full Text] [Related]
19. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. O'Donnell J; Trokoudes K; Silverberg J; Row V; Volpé R J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633 [TBL] [Abstract][Full Text] [Related]
20. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease. Shinozawa T; Villadolid MC; Ingbar SH J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]